Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
American Journal of Hematology
|
December 3, 2019
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
Paul J Hampel, Timothy G Call, Wei Ding, et al.
Blood Cancer Journal
|
May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Yucai Wang, Sutapa Sinha, Linda E Wellik, et al.
Blood
|
April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
Sameer A Parikh, Kari G Rabe, Neil E Kay, et al.
The Oncologist
|
September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia
Paul J Hampel, Timothy G Call, Kari G Rabe, et al.
Annals of Hematology
|
June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes
William J Archibald, Kari G Rabe, Brian F Kabat, et al.
American Journal of Hematology
|
June 18, 2025
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study
Mazie Tsang, Paul J Hampel, Kari G Rabe, et al.
Haematologica
|
November 2, 2020
The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor
Yucai Wang, Kari G Rabe, Michael S Bold, et al.
Blood Cancer Journal
|
March 3, 2021
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
Paul J Hampel, Sameer A Parikh, Timothy G Call, et al.
JACC. Cardiooncology
|
May 22, 2024
Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia
Georgios Christopoulos, Zachi I Attia, Sara J Achenbach, et al.
Blood Cancer Journal
|
September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Paul J Hampel, Kari G Rabe, Timothy G Call, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
American Journal of Hematology
|
December 3, 2019
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
Paul J Hampel, Timothy G Call, Wei Ding, et al.
Blood Cancer Journal
|
May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Yucai Wang, Sutapa Sinha, Linda E Wellik, et al.
Blood
|
April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
Sameer A Parikh, Kari G Rabe, Neil E Kay, et al.
The Oncologist
|
September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia
Paul J Hampel, Timothy G Call, Kari G Rabe, et al.
Annals of Hematology
|
June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes
William J Archibald, Kari G Rabe, Brian F Kabat, et al.
American Journal of Hematology
|
June 18, 2025
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study
Mazie Tsang, Paul J Hampel, Kari G Rabe, et al.
Haematologica
|
November 2, 2020
The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor
Yucai Wang, Kari G Rabe, Michael S Bold, et al.
Blood Cancer Journal
|
March 3, 2021
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
Paul J Hampel, Sameer A Parikh, Timothy G Call, et al.
JACC. Cardiooncology
|
May 22, 2024
Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia
Georgios Christopoulos, Zachi I Attia, Sara J Achenbach, et al.
Blood Cancer Journal
|
September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Paul J Hampel, Kari G Rabe, Timothy G Call, et al.
Page
of 10